QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=D6CE45891B758B23072D12349DA813EB;jsessionid=6D2F68B7549F6F4A461CE39786FBBD7F;jsessionid=006EE7B8C38893D7194A55CC09095620;jsessionid=9E7CD7C5041A9AF388FCB0EC351E8DC6;jsessionid=903D24E764AE5B8F8056B4846B641796 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=D6CE45891B758B23072D12349DA813EB;jsessionid=6D2F68B7549F6F4A461CE39786FBBD7F;jsessionid=006EE7B8C38893D7194A55CC09095620;jsessionid=9E7CD7C5041A9AF388FCB0EC351E8DC6;jsessionid=903D24E764AE5B8F8056B4846B641796